Immunosuppressive nanoparticles slow atherosclerosis progression in animal models

Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with national and international research centers, have identified a key immune cell subtype involved in the development of atherosclerosis. In a study published in Circulation Research, the team tested an experimental therapy in animal models based on immunosuppressive nanoparticles and demonstrated that it can slow disease progression.